- Home
- HTH vs ALVO Comparison
HTH vs ALVO Comparison
Compare HTH & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTH
- ALVO
- Stock Information
- Founded
- HTH 1998
- ALVO 2013
- Country
- HTH United States
- ALVO Luxembourg
- Employees
- HTH N/A
- ALVO N/A
- Industry
- HTH Major Banks
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- HTH Finance
- ALVO Health Care
- Exchange
- HTH Nasdaq
- ALVO Nasdaq
- Market Cap
- HTH 2.1B
- ALVO 2.5B
- IPO Year
- HTH 2004
- ALVO N/A
- Fundamental
- Price
- HTH $35.19
- ALVO $8.05
- Analyst Decision
- HTH Hold
- ALVO
- Analyst Count
- HTH 1
- ALVO 0
- Target Price
- HTH $32.00
- ALVO N/A
- AVG Volume (30 Days)
- HTH 476.7K
- ALVO 482.2K
- Earning Date
- HTH 10-23-2025
- ALVO 08-13-2025
- Dividend Yield
- HTH 2.04%
- ALVO N/A
- EPS Growth
- HTH 27.10
- ALVO N/A
- EPS
- HTH 2.22
- ALVO 0.22
- Revenue
- HTH $1,233,449,000.00
- ALVO $562,478,000.00
- Revenue This Year
- HTH N/A
- ALVO $33.32
- Revenue Next Year
- HTH $1.15
- ALVO $46.16
- P/E Ratio
- HTH $15.89
- ALVO $36.97
- Revenue Growth
- HTH 4.92
- ALVO 82.19
- 52 Week Low
- HTH $26.67
- ALVO $7.35
- 52 Week High
- HTH $35.58
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- HTH 77.84
- ALVO 40.69
- Support Level
- HTH $35.03
- ALVO $7.97
- Resistance Level
- HTH $35.58
- ALVO $8.16
- Average True Range (ATR)
- HTH 0.66
- ALVO 0.34
- MACD
- HTH 0.31
- ALVO -0.04
- Stochastic Oscillator
- HTH 95.98
- ALVO 17.03
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.